This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Profil

JEUGMANS Anne-Marie

Département de médecine interne > Service de rhumatologie

See author's contact details
Main Referenced Co-authors
Reginster, Jean-Yves  (8)
Albert, Adelin  (6)
Franchimont, P (5)
Denis, D (4)
Deroisy, Rita  (3)
Main Referenced Keywords
Biopsy (1); BRAF V600E (1); Chester disease (1); Erdheim (1); Erdheim-Chester Disease/diagnosis/genetics/therapy (1);
Main Referenced Disciplines
General & internal medicine (5)
Rheumatology (3)
Genetics & genetic processes (1)

Publications (total 9)

The most downloaded
194 downloads
DELPORTE, G., Delcorde, I., RORIVE, A., JEUGMANS, A.-M., MOONEN, M., KOOPMANSCH, B., Moonen, G., & Delvenne, P. (2020). Cas clinique. Maladie d’Erdheim-Chester. Revue Médicale de Liège, 75 (4), 213-217. https://hdl.handle.net/2268/252451

The most cited

52 citations (Scopus®)

Reginster, J.-Y., JEUGMANS, A.-M., Albert, A., Denis, D., Deroisy, R., LECART, M.-P., Fontaine, M. A., Collette, J., & Franchimont, P. (1988). Biological and Clinical Assessment of a New Bisphosphonate, (Chloro-4 Phenyl) Thiomethylene Bisphosphonate, in the Treatment of Paget's Disease of Bone. BONE, 9 (6), 349-54. doi:10.1016/8756-3282(88)90115-9 https://hdl.handle.net/2268/125051

DELPORTE, G., Delcorde, I., RORIVE, A., JEUGMANS, A.-M., MOONEN, M., KOOPMANSCH, B., Moonen, G., & Delvenne, P. (2020). Cas clinique. Maladie d’Erdheim-Chester. Revue Médicale de Liège, 75 (4), 213-217.

Reginster, J.-Y., JEUGMANS, A.-M., Franssen, M., Sarlet, N., McIntyre, H. D., & Franchimont, P. (January 1992). The Effect of Nasal hCT on Bone Turnover in Paget's Disease of Bone--Implications for the Treatment of Other Metabolic Bone Diseases. British Journal of Rheumatology, 31 (1), 35-9. doi:10.1093/rheumatology/31.1.35
Peer Reviewed verified by ORBi

Reginster, J.-Y., JEUGMANS, A.-M., Wouters, M., Sarlet, N., Mc Intyre, H., & Franchimont, P. (1992). The effect of nasal hCT on bone turnover in Paget's disease of bone. Implications for the treatment of other metabolic bone diseases. Revue du Rhumatisme et des Maladies Osteo-Articulaires, 59, 528.
Peer Reviewed verified by ORBi

Denis, D., Lecart, M., DEROISY, R., JEUGMANS, A.-M., Albert, A., Reginster, J.-Y., & Franchimont, P. (1989). Un an de traitement de la maladie osseuse de Paget par spray nasal de calcitonine de saumon. Revue Médicale de Liège, 1, 23-27.
Peer reviewed

Reginster, J.-Y., JEUGMANS, A.-M., Albert, A., Denis, D., & Franchimont, P. (June 1988). One Year's Treatment of Paget's Disease of Bone by Synthetic Salmon Calcitonin as a Nasal Spray. Journal of Bone and Mineral Research, 3 (3), 249-52. doi:10.1002/jbmr.5650030302
Peer Reviewed verified by ORBi

Lecart, M., JEUGMANS, A.-M., Albert, A., Denis, D., DEROISY, R., Fontaine, M., COLLETTE, J., Reginster, J.-Y., & Franchimont, P. (1988). Effets biologiques et cliniques d'un nouveau bisphosphonate (chloro-4-phényl) thiométhylène bisphosphonate dans la maladie osseuse de Paget. Revue Médicale de Liège, 24, 799-806.
Peer reviewed

Reginster, J.-Y., JEUGMANS, A.-M., Albert, A., Denis, D., Deroisy, R., LECART, M.-P., Fontaine, M. A., Collette, J., & Franchimont, P. (1988). Biological and Clinical Assessment of a New Bisphosphonate, (Chloro-4 Phenyl) Thiomethylene Bisphosphonate, in the Treatment of Paget's Disease of Bone. BONE, 9 (6), 349-54. doi:10.1016/8756-3282(88)90115-9
Peer Reviewed verified by ORBi

Reginster, J.-Y., Denis, D., JEUGMANS, A.-M., Albert, A., Lambelin, P., Fontaine, M., & Franchimont, P. (1987). Treatment of Paget's disease of bone by a new diphosphonate: SR41319B. Journal of Bone and Mineral Research, 2 (S1), 90.
Peer Reviewed verified by ORBi

Reginster, J.-Y., Denis, D., JEUGMANS, A.-M., Albert, A., Lambelin, P., Fontaine, M., & Franchimont, P. (1987). Treatment of Paget's disease of bone by a new bisphosphonate: SR41319B. Clinical and Experimental Rheumatology, 5 (S2), 75.
Peer Reviewed verified by ORBi

Contact ORBi